New Marketplace

Aggregators, Innovators, and the Resurgence of National Physician Practices

Article · August 16, 2018

Although trends toward physician consolidation into larger groups are widely recognized, the growth of large, for-profit practices with national scope has received comparatively little notice. At least I was unaware of national physician practices (NPPs) until I joined Sound Physicians last year as its Chief Clinical Officer, after many years as a health services researcher and later executive in a large academic health system. Sound specializes in acute care medicine and performance management services, employing more than 3,000 hospitalists, intensivists, and emergency medicine physicians with practices at more than 275 hospitals in 38 states.

NPPs tend to comprise a single specialty or small group of related specialties, including primary care, surgery, orthopedics, anesthesia, and radiology. Sound is by no means the largest; several NPPs, including Envision (primarily emergency medicine) and Mednax (pediatrics), now employ well over 10,000 providers. These groups have grown rapidly over the past several years, either by acquiring existing physician-owned practices or by converting hospital-employed groups. Although most NPPs are privately held, many of the larger companies are now publicly traded.

NPPs are growing in part because there is demand for their services. Many hospitals turn to them because physician management is simply not their forte and they are struggling with clinical performance and efficiency. Hospitals also partner with NPPs when they have difficulties recruiting physicians. With their national scale, NPPs have a strong advantage in this regard, particularly in medical specialties with nationwide shortages, such as hospital medicine and intensive care.

Second, NPPs are growing rapidly because public and private equity markets are funding their acquisition of independent practices. In addition to the continued availability of capital at historically low interest rates following the 2007–2009 financial crisis, professional investors see new opportunities as changing reimbursement models reward higher-quality, lower-cost care delivery.

Pros and Cons of NPPs

Critics can cite several mechanisms by which NPPs could drive up rather than decrease overall health care costs. First, the NPPs could leverage their size and market power to raise rates with insurers and ultimately prices for consumers. NPPs seldom acquire the same degree of leverage with payers that hospitals wield in concentrated markets, but anticompetitive pricing could become an issue in certain locales. Second, overcoding, overbilling, and other aggressive billing practices, though a risk in any setting, are no doubt more common in for-profit environments. For example, one recent study highlighted a spike in exorbitant, out-of-network physician charges for patients treated in emergency rooms managed by two large NPPs.

Finally, NPPs may be more prone to overutilization, at least in specialties where clinical demand is elastic. For example, my research colleagues and I demonstrated a decade ago that markets served by for-profit cardiac care hospitals had higher rates of elective percutaneous coronary interventions and bypass surgery than those served by traditional hospitals. While these various concerns are not new or unique to NPPs, they are legitimate and will require continued surveillance by payers and regulators.

Whether NPPs will deliver better care to patients is the more interesting question. I joined Sound Physicians because its scale, rapid growth, and commitment to innovation were exciting to me. Its core value proposition to clients also aligned with my sensibilities as a health services researcher. Sound will not be successful as a business if it does not deliver better clinical performance than its competitors (or hospitals themselves), or if does not reduce costs around hospitalization episodes. (Sound is among the largest participants in CMS’ Bundled Payment for Care Improvement initiative.) No doubt many other NPPs share similar positioning in other clinical specialties and payment models.

While clinical innovation aimed at improving quality and efficiency is not unique to this sector, NPPs have two major advantages relative to traditional physician practice models: scale and specialization. Their large scale facilitates management practices that reduce unnecessary clinical variation, eliminate waste, and better align clinician staffing and behavior with overall patient, hospital, and payer needs. Scale, along with investor capital, also allows for investments generally out of reach for smaller groups. Sound Physicians, for example, invests heavily, about $15 million per year, in its own national program for physician leadership training and professional development.

In addition, mobile and desktop applications, which overlay the electronic health record systems of its hospital partners, are used to facilitate clinical process redesign, care coordination, and adherence to standardized, evidence-based practices. An organization-wide analytics platform provides physicians with real-time performance feedback on patient experience, throughput, and transitional care measures.

Unlike hospital-based health systems, NPPs can be focused factories devoted to improving care one specialty niche at a time. For example, Fresenius Medical Care, DaVita Medical Group, and their subsidiaries have introduced many advancements in dialysis technology, along with continuous improvement in clinical care models for patients with end-stage renal disease (ESRD). They also helped usher in nationwide standards in performance measurement.

Coincident with their consolidation of the U.S. dialysis market over the past 15 years (they now manage approximately 75%), mortality and hospital admission rates in patients with ESRD have fallen substantially. (Earlier this year, Fresenius Medical Care sold its majority share in Sound Physicians to an investment consortium led by a private equity firm; the transaction closed in June.)

Aggregation vs. Innovation

Today, despite their potential to accelerate change, many NPPs are aggregators rather than innovators. Rather than delivering a new or better clinical service, the primary goal of the aggregator is simply to get bigger, usually by purchasing other practices (including other NPPs). Their overarching business strategy is leveraging scale — spreading fixed administrative costs over a larger clinical base. Professional management techniques drive administrative efficiency, more favorable payer contracting, better revenue cycle management, increased physician productivity, and ultimately, higher profits.

Aggregators predominated during the original heyday of NPPs in the 1990s. As exemplified by the rise and fall of PhyCor and MedPartners in the 1990s, they later struggled as administrative efficiencies failed to outpace financing costs and investment capital abandoned the physician services market, cutting off growth. By 2002, eight of the top ten largest, publicly traded NPPs were under bankruptcy. The landscape is a little different now, with new value-based payment models that advantage larger groups and offer a potential return on investment in innovative care models. Still, current day aggregator NPPs risk the same fate if they fail to leverage their advantages toward higher-value care.

I expect that rigorous, third-party evaluations will confirm the effectiveness of many NPPs in improving patient outcomes and reducing costs. Even if I’m right in this regard, my academic friends will still ask me, “Why should investors take profits out of an already bloated, unaffordable health care system?” My newer, private sector colleagues will respond, “There’s way more waste in nonprofit health systems. And at least we pay taxes.” This ideological divide will never be fully bridged. Nonetheless, I believe there is probably enough inefficiency in the U.S. health care system for everyone — patients, providers, and even investors — to benefit from NPPs that meaningfully disrupt and improve upon existing models of care delivery.

New call for submissions ­to NEJM Catalyst

Now inviting longform articles


A weekly email newsletter featuring the latest actionable ideas and practical innovations from NEJM Catalyst.

Learn More »

More From New Marketplace
Elements of a Sustainable Complex Care Management Contract

Sustainable Financing for Complex Care Management Is Critical to a Value-Driven Health Care System

Care management should be payer-agnostic at its core.

Comparison of Certain Model Features in Blue Cross NC Blue Premier vs Next-Generation ACO Model vs BCBSMA Alternative Quality Contract

Engineering a Rapid Shift to Value-Based Payment in North Carolina: Goals and Challenges for a Commercial ACO Program

We believe North Carolina can be a model for the nation.

Small Molecule Drugs Facing Generic Competition - Orphan and Non-Orphan Drugs - Orphan Drug Act

It’s Time to Reform the Orphan Drug Act

Three proposals for improving the law to reflect 21st-century drug development practices.

Three-Part Pricing of PCSK9 Inhibitors

A New Model for Pricing Drugs of Uncertain Efficacy

Are we paying too much for new drugs before we know how well they work? This innovative pricing model proposes postponing major rewards until efficacy is established — which could help both patients and payers while still paying back investments on the most effective drugs.

what does quality measurement in health care mean

Buzz Survey Report: Addressing the Problems of Quality Measurement

An independent NEJM Catalyst report sponsored by University of Utah Health on patient involvement in quality measurement.

Average HOOS and Average KOOS for patients undergoing hip and knee replacement at CJRI

Building a “Hospital-within-Hospital” Model for Joint Replacements

The Connecticut Joint Replacement Institute has demonstrated that formerly competing independent providers can unite on a common vision to yield drastic improvements in quality, safety, and costs.

Discharge Rates and Follow-Up Internval Dashboard for One Provider at MGH Dermatology

A Successful Pilot to Improve Access by Adjusting Discharge and Follow-Up Rates

Actionable data and modest financial incentives can help motivate clinicians to adjust their behavior around scheduling follow-up appointments.

Cautious Optimism That Value-Based Reimbursement Will Become Primary Revenue Model

Survey Snapshot: What Would Accelerate the Adoption of Value-Based Care?

NEJM Catalyst Insights Council members weigh in on the barriers and path forward to value-based health care.

Strongwater08_pullquote primary care value proposition and disruptive innovation

The Evolution of Primary Care: Embracing Innovation While Protecting the Core Value

Primary care must leverage disruptive innovations to ensure that patients receive first-access, comprehensive, coordinated, continuous care that is woven into a seamlessly integrated system.

Berns01_pullquote nephrologists dialysis facility joint venture conflicts of interest

Dialysis-Facility Joint-Venture Ownership — Hidden Conflicts of Interest

Despite potential benefits, joint ventures between nephrologists and dialysis companies raise legal and ethical concerns because of participants’ conflicts of interest and lack of transparency.


A weekly email newsletter featuring the latest actionable ideas and practical innovations from NEJM Catalyst.

Learn More »


Value Based Care

199 Articles

Curbing Health Care Spending: The Provider’s…

Health care costs have historically grown at about 2% faster than income in the United…

Medicare and Medicaid

122 Articles

A Collaborative Model to Expand Medicaid…

How managing the benefit coverage expansion for the treatment of HCV in New Mexico was…

Vertical Integration and Bold Experimentation

Four points on improving value in health care via vertical integration and aggressive experimentation.

Insights Council

Have a voice. Join other health care leaders effecting change, shaping tomorrow.

Apply Now